BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32609820)

  • 1. Toward a translationally independent RNA-based synthetic oscillator using deactivated CRISPR-Cas.
    Kuo J; Yuan R; Sánchez C; Paulsson J; Silver PA
    Nucleic Acids Res; 2020 Aug; 48(14):8165-8177. PubMed ID: 32609820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of Cas9 and single-guided RNAs in
    Qiao J; Li W; Lin S; Sun W; Ma L; Liu Y
    Commun Biol; 2019; 2():161. PubMed ID: 31069270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a.
    Olivi L; Bagchus C; Pool V; Bekkering E; Speckner K; Offerhaus H; Wu WY; Depken M; Martens KJA; Staals RHJ; Hohlbein J
    Nucleic Acids Res; 2024 May; 52(9):5241-5256. PubMed ID: 38647045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems.
    Zhang Y; Ren Q; Tang X; Liu S; Malzahn AA; Zhou J; Wang J; Yin D; Pan C; Yuan M; Huang L; Yang H; Zhao Y; Fang Q; Zheng X; Tian L; Cheng Y; Le Y; McCoy B; Franklin L; Selengut JD; Mount SM; Que Q; Zhang Y; Qi Y
    Nat Commun; 2021 Mar; 12(1):1944. PubMed ID: 33782402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined genome editing and transcriptional repression for metabolic pathway engineering in Corynebacterium glutamicum using a catalytically active Cas12a.
    Liu W; Tang D; Wang H; Lian J; Huang L; Xu Z
    Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):8911-8922. PubMed ID: 31583448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massively parallel CRISPRi assays reveal concealed thermodynamic determinants of dCas12a binding.
    Specht DA; Xu Y; Lambert G
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11274-11282. PubMed ID: 32376630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
    Berkhout B; Gao Z; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Francisella novicida CRISPR-Cas Systems Can Functionally Complement Each Other in DNA Defense while Providing Target Flexibility.
    Ratner HK; Weiss DS
    J Bacteriol; 2020 May; 202(12):. PubMed ID: 32284320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusing T5 exonuclease with Cas9 and Cas12a increases the frequency and size of deletion at target sites.
    Zhang Q; Yin K; Liu G; Li S; Li M; Qiu JL
    Sci China Life Sci; 2020 Dec; 63(12):1918-1927. PubMed ID: 32382982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
    Swartjes T; Staals RHJ; van der Oost J
    Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
    Swarts DC; van der Oost J; Jinek M
    Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching the activity of Cas12a using guide RNA strand displacement circuits.
    Oesinghaus L; Simmel FC
    Nat Commun; 2019 May; 10(1):2092. PubMed ID: 31064995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Survey of Genome Editing Activity for 16 Cas12a Orthologs.
    Zetsche B; Abudayyeh OO; Gootenberg JS; Scott DA; Zhang F
    Keio J Med; 2020 Sep; 69(3):59-65. PubMed ID: 31723075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9.
    Cui L; Vigouroux A; Rousset F; Varet H; Khanna V; Bikard D
    Nat Commun; 2018 May; 9(1):1912. PubMed ID: 29765036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks.
    Cofsky JC; Karandur D; Huang CJ; Witte IP; Kuriyan J; Doudna JA
    Elife; 2020 Jun; 9():. PubMed ID: 32519675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9.
    Yan F; Wang W; Zhang J
    Cell Biol Toxicol; 2019 Dec; 35(6):489-492. PubMed ID: 31468291
    [No Abstract]   [Full Text] [Related]  

  • 18. Single Cell Characterization of a Synthetic Bacterial Clock with a Hybrid Feedback Loop Containing dCas9-sgRNA.
    Henningsen J; Schwarz-Schilling M; Leibl A; Gutiérrez JN; Sagredo S; Simmel FC
    ACS Synth Biol; 2020 Dec; 9(12):3377-3387. PubMed ID: 33231079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good guide, bad guide: spacer sequence-dependent cleavage efficiency of Cas12a.
    Creutzburg SCA; Wu WY; Mohanraju P; Swartjes T; Alkan F; Gorodkin J; Staals RHJ; van der Oost J
    Nucleic Acids Res; 2020 Apr; 48(6):3228-3243. PubMed ID: 31989168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Type V-A CRISPR Effectors Are Active Nucleases with Expanded Targeting Capabilities.
    Aliaga Goltsman DS; Alexander LM; Devoto AE; Albers JB; Liu J; Butterfield CN; Brown CT; Thomas BC
    CRISPR J; 2020 Dec; 3(6):454-461. PubMed ID: 33146573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.